| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Supplements |
1 From the Institute of Brain Chemistry and Human Nutrition, University of North London.
Arachidonic (AA) and docosahexaenoic (DHA) acids are major components of cell membranes and are of special importance to the brain and blood vessels. In utero, the placenta selectively and substantially extracts AA and DHA from the mother and enriches the fetal circulation. Studies indicate that there is little placental conversion of the parent essential fatty acids to AA and DHA. Similarly, analyses of desaturation and reductase activity have shown the placenta to be less functional than the maternal or fetal livers. There appears to be a correlation with placental size and plasma AA and DHA proportions in cord blood; therefore, placental development may be an important variable in determining nutrient transfer to the fetus and, hence, fetal growth itself. In preterm infants, both parenteral and enteral feeding methods are modeled on term breast milk. Consequently, there is a rapid decline of the plasma proportions of AA and DHA to one quarter or one third of the intrauterine amounts that would have been delivered by the placenta. Simultaneously, the proportion of linoleic acid, the precursor for AA, rises in the plasma phosphoglycerides 3-fold. An inadequate supply of AA and DHA during the period of high demand from rapid vascular and brain growth could lead to fragility, leakage, and membrane breakdown. Such breakdown would predictably be followed by peroxidation of free AA, vasoconstriction, inflammation, and ischemia with its biological sequelae. In the brain, cell death would be an extreme consequence.
Key Words: Arachidonic acid • premature infants • docosahexaenoic acid • enteral nutrition • parenteral nutrition • breast milk • linoleic acid • 
-linolenic acid • neurodevelopmental disorders • vascular-developmental disorders • preterm infant formulas
This article has been cited by other articles:
|
|
 |
|
  D. Bitsanis, M. A. Crawford, T. Moodley, H. Holmsen, K. Ghebremeskel, and O. Djahanbakhch Arachidonic Acid Predominates in the Membrane Phosphoglycerides of the Early and Term Human Placenta J. Nutr., November 1, 2005; 135(11): 2566 - 2571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C McCann and B. N Ames Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals Am. J. Clinical Nutrition, August 1, 2005; 82(2): 281 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vavasour Nutritional Implications of Observed Neurobehavioral Disturbances and Reduced Gestation Length in Infants of Mothers Using Selective Serotonin Reuptake Inhibitors During Pregnancy Pediatrics, July 1, 2004; 114(1): 325 - 325. [Full Text] [PDF]
|
|
|
|
|
|
R. H. de Groot, G. Hornstra, A. C van Houwelingen, and F. Roumen Effect of {alpha}-linolenic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome Am. J. Clinical Nutrition, February 1, 2004; 79(2): 251 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Hasler Functional Foods: Benefits, Concerns and Challenges--A Position Paper from the American Council on Science and Health J. Nutr., December 1, 2002; 132(12): 3772 - 3781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D L Armstrong, C Bagnall, J E Harding, and R L Teele Measurement of the subarachnoid space by ultrasound in preterm infants Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2002; 86(2): F124 - F126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G.D. Allen and M. A. Harris The Role of n-3 Fatty Acids in Gestation and Parturition Experimental Biology and Medicine, June 1, 2001; 226(6): 498 - 506. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
